Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1947 1
1950 1
1952 1
1953 1
1954 3
1955 7
1956 1
1957 1
1958 4
1959 6
1960 1
1961 5
1962 3
1963 2
1964 3
1965 2
1966 2
1967 5
1968 4
1969 3
1970 4
1971 2
1972 4
1973 2
1974 4
1975 2
1976 4
1977 7
1978 10
1979 15
1980 10
1981 7
1982 3
1983 12
1984 5
1985 6
1986 6
1987 5
1988 5
1989 11
1990 12
1991 12
1992 7
1993 5
1994 16
1995 13
1996 20
1997 26
1998 17
1999 22
2000 20
2001 13
2002 21
2003 42
2004 55
2005 43
2006 36
2007 36
2008 39
2009 49
2010 57
2011 65
2012 66
2013 75
2014 90
2015 70
2016 94
2017 95
2018 117
2019 121
2020 115
2021 134
2022 109
2023 119
2024 121
2025 19

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,933 results

Results by year

Filters applied: . Clear all
Page 1
NOD1 and NOD2 signalling links ER stress with inflammation.
Keestra-Gounder AM, Byndloss MX, Seyffert N, Young BM, Chávez-Arroyo A, Tsai AY, Cevallos SA, Winter MG, Pham OH, Tiffany CR, de Jong MF, Kerrinnes T, Ravindran R, Luciw PA, McSorley SJ, Bäumler AJ, Tsolis RM. Keestra-Gounder AM, et al. Among authors: winter mg. Nature. 2016 Apr 21;532(7599):394-7. doi: 10.1038/nature17631. Epub 2016 Mar 23. Nature. 2016. PMID: 27007849 Free PMC article.
Results of the c-TRAK TN trial: a clinical trial utilising ctDNA mutation tracking to detect molecular residual disease and trigger intervention in patients with moderate- and high-risk early-stage triple-negative breast cancer.
Turner NC, Swift C, Jenkins B, Kilburn L, Coakley M, Beaney M, Fox L, Goddard K, Garcia-Murillas I, Proszek P, Hall P, Harper-Wynne C, Hickish T, Kernaghan S, Macpherson IR, Okines AFC, Palmieri C, Perry S, Randle K, Snowdon C, Stobart H, Wardley AM, Wheatley D, Waters S, Winter MC, Hubank M, Allen SD, Bliss JM; c-TRAK TN investigators. Turner NC, et al. Among authors: winter mc. Ann Oncol. 2023 Feb;34(2):200-211. doi: 10.1016/j.annonc.2022.11.005. Epub 2022 Nov 22. Ann Oncol. 2023. PMID: 36423745 Free article. Clinical Trial.
Zoledronic acid.
Coleman R, Burkinshaw R, Winter M, Neville-Webbe H, Lester J, Woodward E, Brown J. Coleman R, et al. Among authors: winter m. Expert Opin Drug Saf. 2011 Jan;10(1):133-45. doi: 10.1517/14740338.2011.540387. Epub 2010 Nov 29. Expert Opin Drug Saf. 2011. PMID: 21114419 Review.
A Probody T Cell-Engaging Bispecific Antibody Targeting EGFR and CD3 Inhibits Colon Cancer Growth with Limited Toxicity.
Boustany LM, LaPorte SL, Wong L, White C, Vinod V, Shen J, Yu W, Koditek D, Winter MB, Moore SJ, Mei L, Diep L, Huang Y, Liu S, Vasiljeva O, West J, Richardson J, Irving B, Belvin M, Kavanaugh WM. Boustany LM, et al. Among authors: winter mb. Cancer Res. 2022 Nov 15;82(22):4288-4298. doi: 10.1158/0008-5472.CAN-21-2483. Cancer Res. 2022. PMID: 36112781 Free PMC article.
Circulating tumour DNA analysis to direct therapy in advanced breast cancer (plasmaMATCH): a multicentre, multicohort, phase 2a, platform trial.
Turner NC, Kingston B, Kilburn LS, Kernaghan S, Wardley AM, Macpherson IR, Baird RD, Roylance R, Stephens P, Oikonomidou O, Braybrooke JP, Tuthill M, Abraham J, Winter MC, Bye H, Hubank M, Gevensleben H, Cutts R, Snowdon C, Rea D, Cameron D, Shaaban A, Randle K, Martin S, Wilkinson K, Moretti L, Bliss JM, Ring A. Turner NC, et al. Among authors: winter mc. Lancet Oncol. 2020 Oct;21(10):1296-1308. doi: 10.1016/S1470-2045(20)30444-7. Epub 2020 Sep 10. Lancet Oncol. 2020. PMID: 32919527 Free PMC article. Clinical Trial.
Gantenerumab: a novel human anti-Aβ antibody demonstrates sustained cerebral amyloid-β binding and elicits cell-mediated removal of human amyloid-β.
Bohrmann B, Baumann K, Benz J, Gerber F, Huber W, Knoflach F, Messer J, Oroszlan K, Rauchenberger R, Richter WF, Rothe C, Urban M, Bardroff M, Winter M, Nordstedt C, Loetscher H. Bohrmann B, et al. Among authors: winter m. J Alzheimers Dis. 2012;28(1):49-69. doi: 10.3233/JAD-2011-110977. J Alzheimers Dis. 2012. PMID: 21955818 Free article.
(Thio)urea Containing Chiral Ammonium Salt Catalysts.
Waser M, Winter M, Mairhofer C. Waser M, et al. Among authors: winter m. Chem Rec. 2023 Jul;23(7):e202200198. doi: 10.1002/tcr.202200198. Epub 2022 Sep 29. Chem Rec. 2023. PMID: 36175162 Review.
Silent bladder perforation.
Kam J, Ainsworth H, Winter M, Lee WG, Ruthven S. Kam J, et al. Among authors: winter m. Br J Hosp Med (Lond). 2015 Aug;76(8):486-7. doi: 10.12968/hmed.2015.76.8.486. Br J Hosp Med (Lond). 2015. PMID: 26255923 No abstract available.
Olaparib and Ceralasertib (AZD6738) in Patients with Triple-Negative Advanced Breast Cancer: Results from Cohort E of the plasmaMATCH Trial (CRUK/15/010).
Ring A, Kilburn LS, Pearson A, Moretti L, Afshari-Mehr A, Wardley AM, Gurel B, Macpherson IR, Riisnaes R, Baird RD, Martin S, Roylance R, Johnson H, Ferreira A, Winter MC, Dunne K, Copson E, Hickish T, Burcombe R, Randle K, Serra V, Llop-Guevara A, Bliss JM, Turner NC. Ring A, et al. Among authors: winter mc. Clin Cancer Res. 2023 Dec 1;29(23):4751-4759. doi: 10.1158/1078-0432.CCR-23-1696. Clin Cancer Res. 2023. PMID: 37773077 Free PMC article. Clinical Trial.
1,933 results